Mylan Q1 2017 Earnings Update
On May 10th, Mylan hosted its Q1 2017 earnings call and briefly discussed its insulin glargine development program.
This content is for Read Less members only.
Already a member? Log in here
Category Archives: Basal Insulin
Lilly Increases Diabetes Manufacturing Investment in 2017
Lilly has announced intentions to invest $850M in its US operations in 2017 including $85M to expand the Trulicity device assembly operations. Additionally, Lilly announced the dedication of a $140M insulin cartridge facility.
This content is for Read Less members only.
Already a member? Log in here
Mylan Q4 ’16 Earnings and Investor Day Update
Mylan hosted its Q4 and full-year 2016 earnings call in conjunction with its investor day and provided an update to the insulin pipeline.
This content is for Read Less members only.
Already a member? Log in here